Trials / Recruiting
RecruitingNCT04838171
Prospective Study of White Blood Cells
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Quell Therapeutics Limited · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | White blood cell and blood collection | Mononucleocytes will be collected via apheresis |
Timeline
- Start date
- 2021-03-24
- Primary completion
- 2029-12-31
- Completion
- 2030-01-01
- First posted
- 2021-04-08
- Last updated
- 2026-01-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04838171. Inclusion in this directory is not an endorsement.